Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2023-02-16 2023-02-14
Drug Identification Number 00392618 00392618
Brand name MAGNESIUM SULFATE INJ 20% USP MAGNESIUM SULFATE INJ 20% USP
Common or Proper name MAGNESIUM MAGNESIUM
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients MAGNESIUM SULFATE MAGNESIUM SULFATE
Strength(s) 200MG 200MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10ML 10ML
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-18 2023-01-18
Estimated end date 2023-02-03 2023-02-03
Actual end date 2023-02-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Baxter item: 5421. Product is available on allocation based on 90% of historical volumes. Baxter item: 5421. Product is available on allocation based on 90% of historical volumes.
Health Canada comments